Long-Acting Amylin Analog
Long-acting amylin receptor agonist studied for appetite suppression, gastric emptying delay, and complementary GLP-1 pathway modulation in metabolic research.
Select Size
Tested by: Eurofins Scientific · Batch: VRC-CAG-2407 · Jul 2026
Cagrillintide is a long-acting amylin analog designed for sustained receptor engagement at amylin (IAPP) receptors. Preclinical and early clinical research has studied its role in appetite suppression via hypothalamic pathways, gastric emptying delay, and complementary effects when combined with GLP-1 receptor agonists. Its distinct mechanism from GLP-1 agonists makes it a valuable research tool in obesity, metabolic syndrome, and dual-mechanism weight regulation studies.
Research Areas
Technical Specifications
Molecular Weight
~3900 g/mol (analog)
Amino Acid Sequence
Long-acting amylin analog — fatty acid conjugated for extended half-life
Storage
Lyophilized: −20°C, stable 24 months. Reconstituted: 4°C, use within 28 days.
Solubility
Soluble in 10mM PBS pH 7.4 at ≥1 mg/mL
For Research Purposes Only. Cagrillintide is sold exclusively for in vitro laboratory research. Not for human consumption, diagnostic, therapeutic, or veterinary use. See our Research Use Disclaimer.